Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance.

García-Marco JA, Jiménez JL, Recasens V, Zarzoso MF, González-Barca E, De Marcos NS, Ramírez MJ, Parraga FJP, Yañez L, De La Serna Torroba J, Malo MDG, Ariznavarreta GD, Persona EP, Guinaldo MAR, De Paz Arias R, Llanos EB, Jarque I, Valle MDCF, Tatay AC, De Oteyza JP, Martin EMD, Fernández IP, Martinez RM, Costa MAA, Champ D, Suarez JG, Díaz MG, Ferrer S, Carbonell F, García-Vela JA; GELLC Study Group.

Haematologica. 2019 Nov;104(11):2249-2257. doi: 10.3324/haematol.2018.204891. Epub 2019 Mar 19.

2.

Efficacy and safety of a feline immunodeficiency virus vaccine.

Huang C, Conlee D, Loop J, Champ D, Gill M, Chu HJ.

Anim Health Res Rev. 2004 Dec;5(2):295-300. Review.

PMID:
15984343
3.

Equine vaccine for West Nile virus.

Ng T, Hathaway D, Jennings N, Champ D, Chiang YW, Chu HJ.

Dev Biol (Basel). 2003;114:221-7.

PMID:
14677692
4.

Risk factors for sporadic infection with Escherichia coli O157:H7.

Mead PS, Finelli L, Lambert-Fair MA, Champ D, Townes J, Hutwagner L, Barrett T, Spitalny K, Mintz E.

Arch Intern Med. 1997 Jan 27;157(2):204-8.

PMID:
9009977
5.

Subsurface cobalt-60 migration from a low-level waste disposal site.

Killey RW, McHugh JO, Champ DR, Cooper EL, Young JL.

Environ Sci Technol. 1984 Mar 1;18(3):148-57. doi: 10.1021/es00121a004. No abstract available.

PMID:
22263727
6.

Supplemental Content

Support Center